Hypertension Clinical Trial
Official title:
Evaluation of Quality of Care - Patient Empowerment Programme, HA
Diabetes mellitus (DM) and hypertension (HT) are major causes of morbidity and among the top
10 causes of deaths in Hong Kong in 2008 (Department of Health 2009). The Hospital Authority
(HA) has initiated service improvement through introducing the patient empowerment programme
(PEP) to improve the quality of care (QOC) for DM and HT patients. The evaluation on the QOC
is an essential part of the programme in order to inform future policy. The Family Medicine
Unit (FMU) of the University of Hong Kong (HKU) has been appointed by the HA to carry out the
evaluation of the QOC of the programme.
The Action Learning and Audit Spiral methodologies to measure whether the target standard of
care intended by the PEP programme is achieved. Each PEP participating clinic and
non-government organization (NGO) will be invited to complete a structured evaluation
questionnaire. The data of all patients who have enrolled into the PEP for more than one year
will be included in the evaluation on the process and outcomes of care. A hundred and thirty
participants will be followed up by telephone to evaluate the effect of the programme in
quality of life (QOL), patient enablement, and global rating of change in health condition at
baseline and 6 months after enrolment. Data on the process of care will be retrieved from the
HA medical records. Main Outcome Measures: The primary outcomes are the proportion of
participants who have received the planned process of care and achieved the target HbA1c and
blood pressure levels.
Data Analysis: Descriptive statistics on proportions meeting the QOC criteria will be
calculated. The changes in clinical, service, and patient reported outcomes at 6 and 12
months will assessed by paired sample t-test. The audit cycle will be repeated annually over
a period of 5 years.
Results: The QOC of the PEP programme will be determined. Areas of deficiency and possible
areas for quality enhancement will be identified. Conclusion: The results of this study will
provide empirical evidence on whether the HA's PEP programme can enhance QOC for patients
with diabetes mellitus (DM) or hypertension (HT). The information will be used to guide
service planning and policy decision making.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |